American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 27, Issue 5 , Pages 314-318 , September 2006

The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis

  • Cengiz Özcan, MD

      Affiliations

    • Department of Otorhinolaryngology, School of Medicine, Mersin University, Mersin, Turkey
    • Corresponding Author InformationCorresponding author. Fındıkpınarı Caddesi, Bugi Sitesi, No. 28 Kuyuluk, 33200 Mersin, Turkey. Tel.: + 90 324 3374300; fax: +90 324 3374305.
    • ,
  • Yusuf Vayisoglu, MD

      Affiliations

    • Department of Otorhinolaryngology, School of Medicine, Mersin University, Mersin, Turkey
    • ,
  • Okan Doğu, MD

      Affiliations

    • Department of Neurology, School of Medicine, Mersin University, Mersin, Turkey
    • ,
  • Kemal Görür, MD

      Affiliations

    • Department of Otorhinolaryngology, School of Medicine, Mersin University, Mersin, Turkey

Received 8 November 2005

References 

  1. Settipane RA, Lieberman P. Update on non-allergic rhinitis. Ann Allergy Asthma Immunol. 2001;86:494–507
  2. Powe DG, Huskinsson RS, Carney AS, et al. Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy. 2001;31:864–869
  3. International Rhinitis Working Group. International consensus report on the diagnosis and the management of rhinitis. Allergy. 1994;49(Suppl 19):5–34
  4. Ayars G. Non allergic rhinitis. Immunol Allergy Clin North Am. 2000;20:283–302
  5. Bachert C. Persistent rhinitis—allergic or nonallergic?. Allergy. 2004;59(Suppl 76):11–15
  6. Shaari CM, Sanders I, Wu BL, et al. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg. 1995;112:566–571
  7. Smith TL. Vasomotor rhinitis is not a wastebasket diagnosis. Arch Otolaryngol Head Neck Surg. 2003;129:584–587
  8. Segal S, Shlamkovitch N, Eviatar E, et al. Vasomotor rhinitis following trauma to the nose. Ann Otol Rhinol Laryngol. 1999;108:208–210
  9. Loehrl TA, Smith TL, Darling RJ, et al. Autonomic dysfunction, vasomotor rhinitis, and extraesophageal manifestations of gastroesophageal reflux. Otolaryngol Head Neck Surg. 2002;126:382–387
  10. Taylor M. The nasal vasomotor reaction. Otolaryngol Clin North Am. 1973;6:645–654
  11. Ciprandi G. Treatment of nonallergic perennial rhinitis. Allergy. 2004;59(Suppl 76):16–23
  12. Schantz EJ, Johnson EA. Properties and uses of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev. 1992;56:80–99
  13. Neuenschwander MC, Pribitkin EA, Sataloff RT. Botulinum, toxin in otolaryngology: a review of its actions and opportunities for use. Ear Nose Throat J. 2000;788–801
  14. Dogu O, Apaydin D, Sevim S, et al. Ultrasound guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Clin Neurol Neurosurg. 2004;106:93–96
  15. Guntinas-Lichius O, Sittel C. Treatment of postparotidectomy salivary fistula with botulinum toxin. Ann Otol Rhinol Laryngol. 2001;110:1162–1164
  16. Guntinas-Lichius O, Eckel HE. Temporary reduction of salivation in laryngectomy patients with pharyngocutaneous fistulas by botulinum toxin A injection. Laryngoscope. 2002;112:187–189
  17. Kým KS, Kým SS, Yoon JH, et al. The effect of botulinum toxin type A injection for intrinsic rhinitis. J Laryngol Otol. 1998;112:248–251
  18. Jaradeh SS, Smith TL, Torrico L, et al. Autonomic nervous system evaluation of patients with vasomotor rhinitis. Laryngoscope. 2000;110:1828–1831
  19. Wilde AD, Cook JA, Jones AS. The nasal response to axillary pressure in non-eosinophilic intrinsic rhinitis. Clin Otolaryngol. 1997;22:219–221
  20. Vayisoglu Y, Ozcan C, Pekdemir H, et al. Autonomic nervous system evaluation using heart rate variability parameters in vasomotor rhinitis patients. J Otolaryngol [in press].
  21. Rohrbach S, Olthoff A, Laskawi R, et al. Botulinum toxin type induces apoptosis in nasal glands of guinea pigs. Ann Otol Rhinol Laryngol. 2001;110:1045–1050
  22. Rohrbach S, Laskawi R. Minimally invasive application of botulinum toxin type A in nasal hypersecretion. ORL J Otorhinolaryngol Relat Spec. 2001;63:382–384
  23. Wang J, Chen F, Meng M, et al. The influence of botulinum toxin type A on vasomotor rhinitis: a morphological study. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2003;17:643–645
  24. Martin PA, Church CA, Petti GH, et al. Visual loss after intraturbinate steroid injection. Otolaryngol Head Neck Surg. 2003;12:280–281
  25. Mabry RL. Intranasal corticosteroid injection: indications, technique, and complications. Otolaryngol Head Neck Surg. 1979;87:207–211

PII: S0196-0709(06)00009-3

doi: 10.1016/j.amjoto.2006.01.008

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 27, Issue 5 , Pages 314-318 , September 2006

Article Tools

* Image Usage & Resolution